Home / Inspections / 1202909

FDA Inspection 1202909 — The Nebraska Medical Center

The Nebraska Medical Center — FEI 3000210077

The FDA completed an inspection of The Nebraska Medical Center on April 11, 2023 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 11, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Omaha, NE (United States)

Facility

Other inspections at this facility

  • 1077742 (NAI Thu Dec 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1025781 (NAI Thu Aug 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935814 (NAI Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 803217 (NAI Fri Oct 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 727158 (NAI Fri May 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources